share_log

中国医药(600056.SH):重庆化医集团将所持重庆医药2%股权无偿划转给通用技术集团

China Meheco Group (600056.SH): Chongqing Huayi Pharmaceutical Group will unconditionally transfer 2% equity of Chongqing Pharmaceutical held by it to General Technology Group.

Gelonghui Finance ·  Nov 28, 2024 04:55

On November 28, Gelonhui: China Meheco Group (600056.SH) announced that on November 28, 2024, the company received a report from Chongqing Medicine regarding the 'Notification Letter' from Meheco Group. Chongqing Meheco Group has obtained the approval from the Chongqing State-owned Assets Supervision and Administration Commission for the free transfer of 2% equity of Chongqing Medicine Health Industry Co., Ltd. held by Chongqing Meheco Holding (Group) Company (Yuzi [2024] No. 544). The Chongqing State-owned Assets Supervision and Administration Commission has approved Chongqing Meheco Group to transfer its 2% equity in Chongqing Medicine to Universal Technology Group without any consideration.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment